Eosinophilic esophagitis (EoE) - top articles from the last few months

Here are my suggestions for some of the top articles about Eosinophilic esophagitis (EoE)from the last few months:

Comparing diet effectiveness in remission of pediatric eosinophilic esophagitis (EoE): Empiric 6-food elimination diet is as effective as a skin test–directed diet in EoE. Elemental diet was better than either one but it is difficult to maintain. http://goo.gl/7L3K1

MicroRNA signature in patients with eosinophilic esophagitis (EoE) predicts reversibility of disease with steroids http://goo.gl/55nto

Ciclesonide is another topical steroid that might offer benefit in treating children with EoE - in addition to fluticasone and oral viscous budesonide (OVB) http://goo.gl/GSu00

Eosinophilic esophagitis induced by milk oral immunotherapy - 3 case reports http://goo.gl/NHljN

Patients with EoE treated with PPIs show an improvement in symptoms despite persistent eosinophilic inflammation. PPI treatment may be useful maintenance therapy in children with EoE. http://goo.gl/bbOhh

Eosinophilic Esophagitis treatment strategy relies on 3 D's: drugs, diets, dilation (free full text review) http://goo.gl/vHu5q

Biomarkers for eosinophilic esophagitis: Eotaxin-3 and IL-13 have emerged as the most promising ones http://buff.ly/PZKKiX

Answers from EoE Experts - YouTube Q&A from Apfed http://buff.ly/PNCzYC

An 8-week treatment with the CRTH2-antagonist has modest benefits in corticosteroid-dependent or CS-refractory EoE http://buff.ly/WSBMqp

EoE vs. PPI-responsive esophageal eosinophilia (PPI-REE) http://buff.ly/J6vsYN and http://buff.ly/J6vq2T

The articles were selected from Twitter @Allergy and RSS subscriptions. Some of the top allergy accounts on Twitter contributed links. I appreciate the curation provided by @Aller_MD @AllergyNet @IgECPD @DrAnneEllis @AACMaven @AllergieVoeding @allergistmommy @mrathkopf @wheezemd.

Please feel free to send suggestions for articles to allergycases AT gmail DOT com and you will receive an acknowledgement in the next edition of this publication.

No comments:

Post a Comment